FY23 task order H - 126361 wedgewood suite M & N expansion MOD 001
Ended Awarded Last action
- Contract number
- 75N91023F00015
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- -$136,805
Award facts
- Opportunity
-
- NCIOSFM230131 Solicitation number
- Contract value 0% obligated
- $16,398,667.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21701, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$136,805 | |
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $888,749 | |
| Other Administrative Action | $0 | |
| Original award | $15,646,723 |
About this award
This delivery order task (H-126361) was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute on September 27, 2023, for the Wedgewood Suite M & N Expansion modification project in Frederick, Maryland. The contract carries a ceiling value of $16.4 million and extends through June 18, 2026, utilizing a cost-plus-fixed-fee pricing structure with no set-aside designation. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center contractor primarily serving the National Cancer Institute and National Institutes of Health, providing comprehensive biomedical research and facilities support services including medical research, clinical trials, facility management, and advanced technological solutions. This task order represents one of numerous cost-plus-fixed-fee delivery orders the company has secured for diverse projects spanning cancer research, vaccine development, clinical trials, and facilities infrastructure improvements.
The Wedgewood facility expansion modification aligns with the National Cancer Institute's infrastructure and facilities management objectives, supporting the ongoing operations at the Frederick National Laboratory for Cancer Research. As a subsidiary of Leidos Holdings, Inc.—a major federal contractor with multi-billion-dollar contract portfolios across defense, intelligence, health, and civilian sectors—Leidos Biomedical Research Inc. brings substantial organizational support and resources to this contract. The task order is issued under a broader delivery order vehicle framework that enables flexible procurement for mission-critical research and operational support without requiring individual full-and-open competitions for discrete projects, allowing the National Cancer Institute to efficiently execute infrastructure and facilities work supporting its research mission.
Quick answers
Who was awarded contract 75N91023F00015?
75N91023F00015 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 27, 2023.
How much is contract 75N91023F00015 worth?
The government has obligated -$136,805 on 75N91023F00015. Its current value, with exercised options, is $16,398,667.
Is contract 75N91023F00015 an order under another contract?
Yes. 75N91023F00015 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91023F00015 competed?
The extent of competition for 75N91023F00015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award